Home › Funds › CPP Investments › SUPN
CPP Investments position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
Latest position (Q2 2026)17.70K sh
Reported value held$823.23K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 61.70K | $1.92M | New |
| Q4 2024 | 2.70K | $97.63K | Reduce |
| Q1 2025 | 7.30K | $239.07K | Add |
| Q2 2025 | 3.50K | $110.32K | Reduce |
| Q3 2025 | 2.50K | $119.47K | Reduce |
| Q4 2025 | 18.80K | $934.36K | Add |
| Q1 2026 | 19.30K | $997.62K | Add |
| Q2 2026 | 17.70K | $823.23K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SUPN
- BlackRock Inc 9.35M sh · $434.87M · Q2 2026
- Vanguard Group 6.05M sh · $300.61M · Q4 2025
- Millennium Management 3.85M sh · $179.21M · Q2 2026
- Geode Capital Management 1.57M sh · $73.04M · Q2 2026
- Renaissance Technologies 1.48M sh · $68.75M · Q2 2026
- Citadel Advisors 1.42M sh · $66.02M · Q2 2026
- Two Sigma Investments 1.18M sh · $55.09M · Q2 2026
- Morgan Stanley 876.84K sh · $40.78M · Q2 2026
- Goldman Sachs Group 819.43K sh · $38.11M · Q2 2026
- D. E. Shaw & Co 767.67K sh · $35.70M · Q2 2026
- Northern Trust Corp 733.37K sh · $34.11M · Q2 2026
- Charles Schwab Investment Management 703.55K sh · $32.72M · Q2 2026